Gaucher Disease Pipeline Review in H1 2017 for Company Profiles Actelion Ltd, Genzyme Corp and Ibiglustat

Gaucher Disease Pipeline is latest pharmaceutical and Healthcare disease pipeline report provides an overview of the Gaucher Disease (Genetic Disorders) pipeline landscape.

Gaucher Disease – Pipeline Review, H1 2017 Companies : Actelion Ltd, Genzyme Corp, greenovation Biotech GmbH, JCR Pharmaceuticals Co Ltd, Lixte Biotechnology Holdings Inc, Neuraltus Pharmaceuticals Inc, Orphazyme ApS, Pharming Group NV, Protalix BioTherapeutics Inc, Shire Plc

Gaucher disease is a rare genetic disorder occurs due to lacks an enzyme called glucocerebrosidase. Symptoms include cognitive impairment, enlarged spleen, severe swelling, lung disease, fatigue and seizures. Treatment includes enzyme replacement therapy.

Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1057942

Drug Profile: ADN-LYS, ambroxol, arimoclomol, AVRRD-02, Gene Therapy for Gaucher Disease, Gene Therapy for Gaucher Disease, ibiglustat, imiglucerase biosimilar, LB-201, LB-205, LTI-291, miglustat, MOSS-GBA, NCGC-607, NP-003, Pcgin, PRX-112, RND-001, taliglucerase alfa, velaglucerase alfa

Gaucher Disease – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Gaucher Disease (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1057942

The Gaucher Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gaucher Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 4, 2, 11 and 2 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 1 and 5 molecules, respectively.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Gaucher Disease (Genetic Disorders).
- The pipeline guide reviews pipeline therapeutics for Gaucher Disease (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Gaucher Disease (Genetic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Gaucher Disease (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Gaucher Disease (Genetic Disorders)

Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1057942

List of Figures
Number of Products under Development for Gaucher Disease, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Targets, H1 2017
Number of Products by Stage and Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017

About Us:          

ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.